Price as of · delayed, not real-time
Specializing in 3D bioprinting technology, this company develops functional human tissues for medical research and therapeutic applications. Investors monitor its progress due to its potential to disrupt drug testing and organ transplantation markets.
No congressional trades have been disclosed for Organovo Holdings, Inc. (ONVO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.